2012
DOI: 10.1253/circj.cj-11-1020
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Transplacental Treatment for Fetal Congenital Bradyarrhythmia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
1
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 21 publications
(22 citation statements)
references
References 38 publications
1
18
1
2
Order By: Relevance
“…20, 21 Our previous study of fetal complete AVB without CHD also showed that the fetal ventricular heart rate was not associated with prognosis. 7 In contrast, our current study revealed that the ventricular heart rate was related to the outcome in fetuses with bradyarrhythmia with CHD. Jaeggi et al also found that a fetal heart rate <60 beats/min was not only associated with fetal hydrops, but predicted an adverse outcome in complete AVB with major CHD.…”
Section: Pmi In the Neonatal Periodcontrasting
confidence: 86%
See 1 more Smart Citation
“…20, 21 Our previous study of fetal complete AVB without CHD also showed that the fetal ventricular heart rate was not associated with prognosis. 7 In contrast, our current study revealed that the ventricular heart rate was related to the outcome in fetuses with bradyarrhythmia with CHD. Jaeggi et al also found that a fetal heart rate <60 beats/min was not only associated with fetal hydrops, but predicted an adverse outcome in complete AVB with major CHD.…”
Section: Pmi In the Neonatal Periodcontrasting
confidence: 86%
“…7 In brief, data were collected using questionnaires sent to Departments of Perinatology and Pediatric Cardiology at 750 institutions in Japan over 7 years (2002-2008). The response rate was 61% (455 institutions).…”
Section: Methodsmentioning
confidence: 99%
“…8,11,12 Ritodrine, a β2-adrenoceptor agonist, is widely used to treat tocolysis, as well as fetal bradyarrhythmias. 19 However, ritodrine can lengthen cardiac contractions, and increase the heart rate, thus increasing the myocardial oxygen consumption, which sometimes leads to myocardial ischemia. Two reports described tocolysis-related AMI during pregnancy.…”
Section: Risk Factorsmentioning
confidence: 99%
“…In contrast, European groups showed that antenatal steroids did not have any significant effect on intrauterine or neonatal survival . A Japanese group also showed that survival rates did not significantly differ in fetuses with or without steroid treatment . Recently, Izmirly et al reported that the prompt use of fluorinated steroids did not prevent further progression and mortality in CAVB fetuses .…”
Section: Discussionmentioning
confidence: 98%